← Leaderboards
Robert E. Lewis
University Of Nebraska Medical Center
$14,454,663
Attributed
$14,454,663
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,364,155 · 10
By mechanism
P20$25,238,192 · 4
R01$7,459,407 · 4
R21$397,693 · 1
P30$268,863 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Heidi Vieira$116,179
- Beth Neilsen$165,389
- Manabu Furukawa$784,788
- Shrabasti Roychoudhury$453,050
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularAffectSmall MoleculeCellsIn VivoProgramsResearch PersonnelPre-Clinical ModelGrantMemberValidationFacultyMediatingInterestProteinsSignal TransductionScaffoldGenerationsInsightFundingResourcesRegulationMalignant NeoplasmsNebraska
Grant awards (57)
Nebraska Center for Molecular Target Discovery and Development$2,302,498
P20 · FY2025 · GM · contact PI
Administrative Core$1,379,388
P20 · FY2025 · GM · contact PI
Regulation of RBP Function during EMT$420,208
R01 · FY2025 · CA · contact PI
Nebraska Center for Molecular Target Discovery and Development$2,302,498
P20 · FY2024 · GM · contact PI
Administrative Core$533,604
P20 · FY2024 · GM · contact PI
Regulation of RBP Function during EMT$433,583
R01 · FY2024 · CA · contact PI
Targeting Endometrial Cancer with Novel Small Molecule Modulators of PP2A$307,000
P20 · FY2024 · GM · contact PI
Nebraska Center for Molecular Target Discovery and Development$2,302,500
P20 · FY2023 · GM · contact PI
Administrative Core$500,157
P20 · FY2023 · GM · contact PI
Nebraska Center for Molecular Target Discovery and Development$2,270,230
P20 · FY2022 · GM · contact PI
Administrative Core$1,168,853
P20 · FY2022 · GM · contact PI
Development of Spatial Transcriptomics Capability$250,000
P20 · FY2022 · GM · contact PI
Novel Mechanisms Controlling SCLC Tumor Initiation$208,437
R21 · FY2022 · CA · contact PI
Pancreatic cancer variant analysis of the All of Us cohort$115,125
P20 · FY2022 · GM · contact PI
Nebraska Center for Molecular Target Discovery and Development$2,270,230
P20 · FY2021 · GM · contact PI
Administrative Core$793,300
P20 · FY2021 · GM · contact PI
Novel Mechanisms Controlling SCLC Tumor Initiation$189,256
R21 · FY2021 · CA · contact PI
Nebraska Center for Molecular Target Discovery and Development$2,270,230
P20 · FY2020 · GM · contact PI
Administrative Core$666,812
P20 · FY2020 · GM · contact PI
Cancer Genes and Molecular Regulation (CGMR)$59,992
P30 · FY2020 · CA · contact PI
Nebraska Center for Molecular Target Discovery and Development$2,270,230
P20 · FY2019 · GM · contact PI
Administrative Core$663,762
P20 · FY2019 · GM · contact PI
Cancer Genes and Molecular Regulation (CGMR)$59,992
P30 · FY2019 · CA · contact PI
Nebraska Center for Molecular Target Discovery and Development$2,248,951
P20 · FY2018 · GM · contact PI
Administrative Core$589,270
P20 · FY2018 · GM · contact PI
Cancer Genes and Molecular Regulation (CGMR)$61,139
P30 · FY2018 · CA · contact PI
Cancer Genes and Molecular Regulation (CGMR)$34,108
P30 · FY2017 · CA · contact PI
Novel Effectors of Colon Tumorigenesis$309,559
R01 · FY2016 · CA · contact PI
Cancer Genes and Molecular Regulation (CGMR)$53,632
P30 · FY2016 · CA · contact PI
Novel Effectors of Colon Tumorigenesis$309,559
R01 · FY2015 · CA · contact PI
Novel Effectors of Colon Tumorigenesis$300,272
R01 · FY2014 · CA · contact PI
Novel Effectors of Colon Tumorigenesis$292,589
R01 · FY2013 · CA · contact PI
Novel Effectors of Colon Tumorigenesis$319,933
R01 · FY2012 · CA · contact PI
KSR, a Modifier of Ras-Mediated Cell Transformation$257,885
R01 · FY2012 · CA · contact PI
KSR, a Modifier of Ras-Mediated Cell Transformation$257,885
R01 · FY2011 · CA · contact PI
KSR, a Modifier of Ras-Mediated Cell Transformation$265,861
R01 · FY2010 · CA · contact PI
PILOT PROJECT 1 UBIQUITIN-MEDIATED REGULATION OF KINASE SUPPRESSOR OF RAS1$33,554
P20 · FY2010 · RR · contact PI
Intracellular Regulators of Insulin Signaling$286,759
R01 · FY2009 · DK · contact PI
KSR, a Modifier of Ras-Mediated Cell Transformation$265,861
R01 · FY2009 · CA · contact PI
KSR, a Modifier of Ras-Mediated Cell Transformation$41,573
R01 · FY2009 · CA · contact PI
Intracellular Regulators of Insulin Signaling$286,759
R01 · FY2008 · DK · contact PI
KSR, a Modifier of Ras-Mediated Cell Transformation$265,861
R01 · FY2008 · CA · contact PI
KSR, a Modifier of Ras-Mediated Cell Transformation$40,535
R01 · FY2008 · CA · contact PI
Intracellular Regulators of Insulin Signaling$292,611
R01 · FY2007 · DK · contact PI
Intracellular Regulators of Insulin Signaling$301,350
R01 · FY2006 · DK · contact PI
KSR, a Modifier of Ras Mediated Cell Transformation$255,511
R01 · FY2006 · CA · contact PI
KSR, a Modifier of Ras Mediated Cell Transformation$33,532
R01 · FY2006 · CA · contact PI
KSR, a Modifier of Ras Mediated Cell Transformation$261,660
R01 · FY2005 · CA
Intracellular Regulators of Insulin Signaling$227,851
R01 · FY2005 · DK
KSR, a Modifier of Ras Mediated Cell Transformation$276,360
R01 · FY2004 · CA
Intracellular Regulators of Insulin Signaling$227,851
R01 · FY2004 · DK
KSR, a Modifier of Ras Mediated Cell Transformation$261,660
R01 · FY2003 · CA
Intracellular Regulators of Insulin Signaling$227,851
R01 · FY2003 · DK
KSR, a Modifier of Ras Mediated Cell Transformation$6,368
R01 · FY2003 · CA
Intracellular Regulators of Insulin Signaling$275,985
R01 · FY2002 · DK
KSR, a Modifier of Ras Mediated Cell Transformation$254,401
R01 · FY2002 · CA
CONTROL OF ADIPOGENESIS AND METABOLISM BY INSULIN$201,734
R01 · FY2000 · DK